CMAJ • May 23, 2006; 174 (11). First published May 2, 2006; doi:10.1503/cmaj.051679
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Abstract
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lévesque, L. E.
Right arrow Articles by Zhang, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lévesque, L. E.
Right arrow Articles by Zhang, B.
Related Collections
Right arrow Heart failure
Right arrow Drugs: cardiovascular system
Right arrowRelated Article

Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

Linda E. Lévesque, James M. Brophy and Bin Zhang

From the Department of Epidemiology and Biostatistics (Lévesque, Brophy, Zhang) and the Department of Medicine, McGill University Health Centre (Brophy), McGill University, Montréal, Que., and the Department of Community Health and Epidemiology, Queen's University, and Kingston, Frontenac, Lennox and Addington Public Health, Kingston, Ont. (Lévesque)


Figure 112
View larger version (16K):

[in a new window]
  		Fig. 1: Patterns of use among current users of rofecoxib and celecoxib who had an acute myocardial infarction (MI).

 

View this table:

[in a new window]
  		Table 1.

 

View this table:

[in a new window]
  		Table 2.

 

View this table:

[in a new window]
  		Table 3.

 

Figure 212
View larger version (17K):

[in a new window]
  		Fig. 2: Adjusted rate ratios as a function of time after treatment is discontinuted.